Monolithic Power, Ascendis Pharma And More: CNBC's 'Final Trades' - Ascendis Pharma (NASDAQ:ASND), Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ:GPIQ)
Benzinga·2025-12-09 13:16

On CNBC's “Halftime Report Final Trades,” on Monday, Amy Raskin, chief investment officer at Chevy Chase Trust, named Ascendis Pharma A/S (NASDAQ:ASND) as her final trade.According to recent news, the U.S. Food & Drug Administration (FDA) on Nov. 25 extended the review period for Ascendis Pharma's New Drug Application (NDA) for TransCon CNP (navepegritide) for children with achondroplasia. The FDA said the information submitted on Nov. 5, related to the post-marketing requirement constituted a major amendme ...